Profitability
This table compares Cyanotech and its rivals’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Cyanotech | -0.25% | -0.86% | -0.30% |
| Cyanotech Competitors | -2,303.77% | -221.68% | -17.78% |
Risk and Volatility
Cyanotech has a beta of 0.1, meaning that its share price is 90% less volatile than the S&P 500. Comparatively, Cyanotech’s rivals have a beta of -3.16, meaning that their average share price is 416% less volatile than the S&P 500.
Insider & Institutional Ownership
24.4% of Cyanotech shares are held by institutional investors. Comparatively, 32.7% of shares of all “Pharmaceuticals” companies are held by institutional investors. 34.4% of Cyanotech shares are held by company insiders. Comparatively, 14.0% of shares of all “Pharmaceuticals” companies are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Earnings and Valuation
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Cyanotech | $26.59 million | -$1.28 million | -1.56 |
| Cyanotech Competitors | $3.57 billion | $3.15 billion | 542.60 |
Cyanotech’s rivals have higher revenue and earnings than Cyanotech. Cyanotech is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
Summary
Cyanotech beats its rivals on 5 of the 9 factors compared.
About Cyanotech
Cyanotech Corp. engages in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition markets worldwide. Its products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant, which is used as a human dietary supplement and dietary ingredient to support and maintain the body’s natural inflammatory response, enhance skin, and support eye, joint, and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement that is used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. The company was founded by Gerald R. Cysewski in 1983 and is headquartered in Kailua-Kona, HI.
Receive News & Ratings for Cyanotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cyanotech and related companies with MarketBeat.com's FREE daily email newsletter.
